All-case Japanese post-marketing surveillance of the real-world safety and efficacy of rituximab treatment in patients with refractory nephrotic syndrome

ConclusionThe safety and efficacy of rituximab treatment in patients with refractory nephrotic syndrome were confirmed in the real-world setting.Clinical trial registrationUMIN000014997.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research